Genomic Vision Strengthens Leadership Team With the Appointment of Frederic Hammel as Chief Operating Officer
Genomic Vision a Euronext-listed biotechnology company that develops products and services for the highly accurate characterization of DNA sequences, today announces the appointment of Frederic Hammel as Chief Operating Officer, further strengthening its leadership team.
Frederic is an accomplished operational manager with more than 25 years of experience in the healthcare industry. Before joining Genomic Vision he was the CEO of Ethera, a company that produces in air-quality products. Prior to that, he held the position of CEO at Platine Pharma Services SAS (later acquired by a company of Bio Mérieux), a contract research organization focused on immune monitoring and validation of diagnostic immune assays and of TxCell, a clinical-stage biotech developing cell-based immunotherapies. At Genomic Vision, Frederic will be responsible for managing all operational aspects of the company.
Latest Aithority Insights : Got It AI Announces AutoFlows, a Breakthrough Autonomous Conversational AI
Frédéric Hammel, Chief Operating Officer at Genomic Vision, said: “I am thrilled to be a part of this dynamic team, committed to delivering excellence to our customers, particularly as we explore new applications for this robust technology and pave the way for advancements in genomics.”
Frederic will be supported in his role by the newly appointed Director of Human Resources, Claire Fleury. She brings more than 20 years of experience in human resources, most recently at real estate company Group Horizon, and holds a BSc in Psychology from Université de Reims-Champagne Ardennes, France and a Master’s in Human Resources and Management from the University of Geneva, Switzerland. In her new role Claire will oversee Genomic Vision’s HR activities.
Claire Fleury, Director of Human Resources at Genomic Vision, said: “Being a part of Genomic Vision means having the belief that anything is achievable, and that the resources to make it happen are within our reach. I am thrilled to be a part of the company’s teams, which are composed of experts, dynamic individuals, and positive thinkers who are working on innovative projects to improve human health.”
AI News: An Investment Into Artificial Intelligence as Daktela Buys Coworkers.ai
Aaron Bensimon, Chief Executive Officer of Genomic Vision, commented: “We are delighted to welcome Claire and Frederic to the Genomic Vision management team as we further establish a strong business providing exceptional genomic analysis solutions to our clients. Frederic brings extensive knowledge of the biotech field and experience in the innovative therapies, which will be a great asset to our team. Additionally, we are pleased Claire has joined us, where she will play an important role supporting our workforce and helping them reach their full potential.”
AiThority Interview : AiThority Interview with Hardy Myers, SVP of Business Development & Strategy at Cognigy
[To share your insights with us, please write to sghosh@martechseries.com]
Comments are closed.